RGA-8, a protein with membrane binding and actin regulatory motifs, promotes embryonic morphogenesis by localizing active CDC-42 in developing epithelia, thus controlling actin and actin motors during cell movements.
Introduction
Organ and tissue formation are highly regulated processes during embryonic development. During embryogenesis, epithelial cells must develop and maintain apicobasal polarity and healthy cell-cell junctions as they move past or over other tissues in the process of morphogenesis. Defects in this process can lead to birth defects, or premature death. Epidermal morphogenesis in C. elegans can be divided into several stages. Epidermal cells are born at the posterior and dorsal surface of the embryo and become arranged in three types of adjacent cells with distinct behaviors -two rows of dorsal cells, and on each side of the embryo, two rows of lateral seam cells, and two rows of ventral cells, (Fig. 1A) .
Epidermal morphogenesis in the nematode
Epidermal morphogenesis begins when two outer rows, right and left ventral epidermal cells, migrate ventrally, pulling along other epidermal rows to enclose the embryo in a process known as ventral enclosure. This tissue migration is led by the two anterior-most ventral cells on each side, the leading cells. The leading cells reach the ventral midline first, while the more posterior ventral cells, the pocket cells, undergo a purse-like constriction, to enclose the embryo on the ventral side. Simultaneously, the two dorsal rows undergo dorsal intercalation to generate a single row of cells, in a process analogous to vertebrate convergent extension.
Epidermal elongation, the process that squeezes the embryo into a worm shape, begins when the two rows of lateral seam cells increase their length along the anterior to posterior axis, and decrease along the dorsal/ventral axis. The dynamics of actin and actomyosin contractility that regulate epidermal morphogenesis are regulated by the Rho GTPases.
In C. elegans, the three main GTPases, Rac1/CED-10, CDC-42 and RhoA/RHO -1, have been shown to be involved in some aspects of epidermal morphogenesis. Ventral enclosure is regulated by the GTPase Rac1/CED-10, which activates WAVE/Scar, a nucleation promoting factor (NPF) that activates branched actin formation through Arp2/3 [4, 5, 6] . Rac1/CED-10 and WAVE/Scar also regulate dorsal intercalation ( Epidermal elongation depends on regulated actomyosin driven by the GTPase RHO-1/RhoA (Reviewed in [13] Vuong-Brender et al., 2016). Actomyosin is negatively regulated by MEL-11/MYPT, which is expressed in the dorsal and ventral epidermis ( [13] Wissman et al., 1999). In the absence of MEL-11 embryos burst due to increased tension on adherens junctions. Actomyosin contractility in the seam cells is promoted by Rho Kinase LET-502/ROCK, which is expressed in the epidermal seam cells ( [13] Wissman et al., 1999).
Removing LET-502/ROCK caused defects in elongation of the embryo. Activation of myosin II is achieved mainly through the LET-502/Rho kinase, but two additional kinases can contribute to maintain myosin II activity. P21-activated kinase PAK-1 and CDC-42-activated kinase MRCK-1 act in parallel to LET-502, since their loss enhances let-502 mutant severity.
MRCK-1 acts upstream of MEL-11 ([14] and is under the regulation of CDC-42 [15] . The role actomyosin contractility plays during ventral migration is not clear. ANI-1, a multidomain protein that organizes actomyosin contractility, is required to ensure proper alignment of contralateral leading-edge epidermal cells meeting at the ventral midline.
However, expression of ANI-1 was not detected in the epidermal cells, leading to the suggestion that ANI-1's action may be due to the interaction between the underlying neuroblast (neuron precursors) with the migrating epidermal cells. Interestingly, loss of rho-1, let-502 or mel-11 led to ventral enclosure defects, but it was not clear if this was due to roles in the neuroblasts or in the epidermis ( Altogether, the evidence suggests RHO-1/RhoA and myosin also contribute to ventral enclosure.
Here we investigate a proposed novel regulator of CDC-42 during ventral enclosure in C. elegans. We identify the RhoGAP and BAR domain protein, RGA-8, as a regulator of CDC-42, based on genetic interactions with cdc-42, wsp-1, and with the toca-2(ng11);toca-1(tm2056) double mutant. A CRISPR generated rga-8 null allele, pj60, is tested for effects on a CDC-42 biosensor. Using RGA-8 endogenously-tagged via CRISPR, we examine RGA-8 distribution in epidermal cells and in polarized epithelia of the pharynx and intestine. The rga-8(pj60) null mutant and WASP-1 mutant wsp-1(gm324) are examined for effects on nonmuscle myosin II (NMY-2::GFP) at the leading edge of migrating epidermal pocket cells during ventral enclosure. We propose a model where RGA-8 and TOCA-1/TOCA-2, through CDC-42, WSP-1 and myosin kinase MRCK-1, enrich and maintain polarized NMY-2::GFP accumulation at the epidermal pocket cells to support ventral enclosure.
Results

RGA-8 is a GAP for CDC-42 that regulates C. elegans embryonic morphogenesis
To characterize the regulators of CDC-42 during epidermal morphogenesis, we screened the C. elegans family of GTPase activating proteins (GAPs), which inactivate and turn over the GTPases ([27]Neukomm et al., 2011) and compared them to the epidermal morphogenesis phenotype for CDC-42 pathway genes using dlg-1::gfp transgenic strain (FT250; [28] Totong et al., 2007) . First we knocked down cdc-42 via RNAi by feeding cdc-42 double stranded RNAi to L1 worms and waiting 2 days. Under these conditions the RNAi knockdown resulted in approximately 70% embryonic lethality in their progeny, yielding the highest embryonic death during ventral enclosure stage at 61%, followed by elongation stage at 10%, and early differentiation at only 2.6% ( Fig. 1 A-D, Table 2 ). We hypothesized that removing GAPs from cdc-42 RNAi, which creates a hypomorphic cdc-42 background, might rescue embryonic lethality. We focused on one candidate CDC-42 GAP, named Rho-GTPase activating protein-8 (RGA-8). We generated an rga-8 deletion allele, pj60, using CRISPR ( Fig. 1D ) and found it rescued cdc-42 RNAi embryonic lethality from 67% to 46% (Fig. 1E ).
rga-8 was thus a candidate GAP for CDC-42.
To investigate which step of embryogenesis is regulated by RGA-8 and the CDC-42 pathway, we crossed mutants or fed RNAi food to dlg-1::gfp which is expressed at C. elegans apical junctions, and thus allowed us to monitor cell migration and cell shape changes. dlg-1::gfp; rga-8(pj60), resulted in 4% embryonic lethality, with approximately half the embryos arresting during ventral enclosure, and the other half during elongation (Tables 1,2 ). Another rga-8 allele, ok3242, a 611 bp deletion that causes a frame shift and premature stop codon, truncating RGA-8 part way through the GAP domain ( Fig. 1D ), showed higher embryonic lethality, at 7% (8.4% in dlg-1::gfp background) ( Fig. 1C,E) . We inactivated the GAP domain of RGA-8 by creating a CRISPR allele, pj71, which switches the catalytic Arginine to an Alanine, and measured 13% embryonic lethality, with arrests during ventral enclosure and elongation ( Fig. 1C ,D,E). Thus, rga-8 has a role in two steps of epidermal morphogenesis, and its RhoGAP domain appears to be involved in this process.
We next investigated if RGA-8 interacted with known components of CDC-42 pathway:
TOCA-1, TOCA-2 and WASP/WSP-1. WASP/WSP-1 is a branched actin nucleation promoting factor that is autoinhibited until it binds TOCA and CDC-42. Activated WASP-1 promotes branched actin formation through the Arp-2/3 complex (Reviewed in [ (Table 2 ). Genetic doubles with wsp-1(gm324), a known effector of cdc-42 that regulates ventral enclosure [5] , resulted in embryonic lethality more similar to loss of wsp-1, at approximately 28%, suggesting that WSP-1 may be epistatic to RGA-8.
Collectively, our results suggested that RGA-8 works with CDC-42 to regulate embryogenesis, possibly parallel to TOCA-1/TOCA-2, and upstream of WSP-1.
RGA-8 acts in parallel to RHO-1 and CED-10/Rac1 during C. elegans morphogenesis
The homologs of RGA-8, SH3BP1, RICH-1 and NADRIN, are proposed GAPs for the GTPase Rac1. If RGA-8 was a GAP for the GTPase Rac1/CED-10, we expected it to rescue the hypomorphic alleles of ced-10. Genetic doubles with two hypomorphic alleles, ced-10(n1993) and ced-10(n3246), resulted in lethality that reflected the ced-10 alleles, from 10.6% to 10.5%, and 22.8% to 24.6% ( Table 1 ). Combining the pj60 mutant with partial depletion of the Rac-1-dependent WAVE/WVE-1 protein, via wve-1 RNAi, ( Table 1 ). This suggested that RGA-8 is not a Rac1 GAP and instead functions in parallel with the Rac1-WAVE/SCAR branched actin pathway to mediate embryogenesis of C.
elegans.
We tested RGA-8 genetic interactions with the RHO-1 pathway. Embryonic lethality due to RNAi of the Rho-1 kinase let-502 was increased by the putative null allele rga-8(pj60) from 46% to 66%, and also increased by the pj71 GAP mutant. Embryonic lethality due to reduced myosin phosphatase, mel-11, via RNAi, was increased in rga-8(pj60) or rga-8(pj71) embryos ( Table 1 ). These results suggest rga-8 acts in parallel to the RHO-1 pathway.
Collectively, we suggest RGA-8 is a GAP for CDC-42, since putative null deletion mutations and RNAi depletion show genetic interactions with components of CDC-42 pathway signaling, including suppression of cdc-42 lethality.
RGA-8 is expressed in most cells with preferred localization at apical pharyngeal and intestinal cells.
To examine the expression pattern of RGA-8, we endogenously-tagged it at the Nterminus with mKate2, a red fluorophore, using CRISPR technology ([31]Dickinson et al, 2015) ( Fig. 1D ). Confocal spinning disk microscopy showed diffuse signal in most cells, with enrichment of mKate2::rga-8 at apical regions of two epithelia, pharynx and intestine ( Fig.  2A ,B). Apical enrichment starts at approximately 240 min after first cleavage, at a time when apical junctions are being established, and is maintained until adulthood. Apical enrichment in epithelia is also seen in the transgenic strain, gfp::cdc-42 ( Fig. 2A,B ; [17] Kumfer et al., 2010) .
RGA-8 regulates apical enrichment of GFP::CDC-42
If RGA-8 is a GAP that regulates CDC-42, it may alter the levels of CDC-42. Crossing the rga-8(pj60) deletion allele into a rescuing transgene, gfp::cdc-42 (WS4700; [32] Neukomm et al., 2014), resulted in increased gfp::cdc-42 levels at the apical intestine and apical pharynx ( Fig. 2D ). Other regions with high gfp::cdc-42 expression, like the nerve ring, also showed higher expression in rga- 8(pj60) . This result suggested that RGA-8 regulates CDC-42.
Intestinal expression:
We examined the subcellular localization of mKate2::rga-8, relative to other proteins, at the apical intestine in L1 larvae. Viewing the images as cross-section projections, showed mKate2::rga-8 is enriched all around the lumen of the intestine ( Fig.   2E ,F). This is different than the localization of apical junction marker, dlg-1::gfp, that localizes at two puncta ( Fig. 2F ). We compared mKate2::rga-8 to erm-1::gfp which is enriched at the most apical regions of intestine ([33] Gobel et al., 2004) and found that mKate2::rga-8 localizes more basally than erm-1::gfp, suggesting that RGA-8 is not found in the microvilli Fig. 3B ). We conclude that RGA-8 is expressed in the epidermal cells, and it is enriched in regions that are also enriched with actin regulators. 
RGA-8 colocalizes with active CDC-42 in some tissues
Loss of CDC-42 affects Pcdc-42::gbd-wsp-1::gfp but not mKate::rga-8 at apical intestine.
If RGA-8 is a GAP for CDC-42, we predicted loss of CDC-42 would not affect it. While 
RGA-8 regulates apical/basal distribution of a CDC-42 biosensor
RGA-8 localization relative to CDC-42 biosensor in epidermis:
To test if RGA-8 regulates active CDC-42 in the epidermis, we first examined the gbd-wsp-1::gfp pattern at the ventral epidermis during enclosure. gbd-wsp-1::gfp is enriched at cell boundaries, but we did not detect obvious enrichment at the ventral midline. We examined the lateral seam cells that drive the first part of epidermal elongation. Pcdc-42::gbd-wsp- the genes are found. We detected increased F-actin in wsp-1(gm324) and rga-8(pj60) mutants in leading-edge cells undergoing ventral enclosure, relative to controls. Similarly, depleting cdc-42 via RNAi, and measuring F-actin only in embryos that do not arrest early, showed elevated epidermal F-actin levels (Fig. 5A, B ). toca-2; toca-1 double mutants did not significantly alter epidermal F-actin levels. Therefore, a proposed CDC-42 pathway that includes RGA-8 and WSP-1 appears to be required to maintain appropriate F-actin levels in the migrating epidermal cells.
Protrusions dynamics are not significantly affected by the CDC-42 pathway
Ouellette and colleagues showed decreased dynamics in wsp-1 mutants, measured as how much the leading-edge membrane is displaced in the leading cells ( [21] Ouellette et al., 2016), although they did not examine F-actin levels. In contrast, we examined the dynamic formation of protrusion and retractions at the leading edge. We detected no significant change, though the number of protrusions was slightly increased in wsp-(gm324) and rga-8(pj60) mutants ( Fig. 5C,D) . Therefore, the elevated F-actin levels seem to not significantly perturb dynamics.
Speed of ventral enclosure is affected by the CDC-42 pathway.
To test how changes in F-actin were affecting morphogenesis, we used the speed of migration as a phenotypic readout. To monitor timing for ventral enclosure using the epidermal F-actin movies, we measured from the time of the first protrusion to the first meeting at the ventral midline for the contralateral leading cells. rga-8(pj60) epidermal leading-edge cells migrate at slower rate (48min) compared to the wild type (24min), while wsp-1(gm324) and the toca-2;toca-1 showed slight delays relative to controls that were not statistically significant.
RGA-8 and CDC-42 pathway regulate NMY-2/myosin in epidermal cells.
While CDC-42 has been connected to ventral enclosure, it is not clear which effectors of cdc-42 loss via RNAi caused variable changes in the level of NMY-2/myosin II in the migrating pocket epidermal cells, perhaps due to the complex effects of depleting cdc-42. In contrast, wsp-1(gm324) pocket cells consistently showed a 20% reduction compared to wild type. Similarly, the rga-8(pj60) putative null mutant caused a 22% reduction compared to wild type. Interestingly, removing both TOCA-1 and TOCA-2 did not significantly change NMY-2/myosin II enrichment, while a triple mutant that removes all three, toca-2(ng11); toca-1(tm2016) rga-8(pj60), restored the level of NMY-2/myosin II back to wild type levels. A small deletion of rga-8, ok3242, predicted to truncate the C terminus, caused a 30% increase in myosin II/NMY-2, while the GAP point mutation, rga-8(pj71) caused a 15% drop, more similar to complete loss of rga-8 (Fig. 6C ). Measurements of myosin levels in the migrating leading cells showed similar changes, with approximately 20% drop in rga-8(pj60) (not shown). Thus, RGA-8 and CDC-42 pathway proteins regulate accumulation of myosin II/NMY-2 in enclosing epidermal cells ( Fig. 6 ).
RGA-8 and CDC-42 regulate the myosin light chain kinase, MRCK-1, in epithelia
To address how changes in cdc-42 pathway genes may result in altered myosin levels, we 
Discussion
The GTPase activating protein (GAP) family consists of many members to regulate a smaller number of RHO-GTPases. In C. elegans, there are only 7 RHO-GTPases in with other proteins, perhaps other GAPs. Since RGA-8 has a BAR domain, we investigated if it localized to specific subcellular membranes. We found it has diffused enrichment around apical epithelia, and may only be transiently enriched at epidermal membranes ( Fig. 3) .
Shared phenotypes with CDC-42 pathway: The phenotypes of three rga-8 alleles and of cdc-42 pathway components suggested a common function during epithelial morphogenesis. In particular, we found that deletion alleles of the toca-2; toca-1 double, or rga-8, or wsp-1, or cdc-42 RNAi, led to similar embryonic lethality with arrests during both ventral enclosure and elongation, and expanded intestinal apical lumen (Fig. 1B,C) . Mutations in RGA-8 led to highly penetrant changes in epidermal cell migration timing, in levels of epidermal F-actin and in levels of epidermal myosin (Fig. 5, 6 ). Similar changes were also seen in mutations of toca-2;toca-1, wsp-1, and cdc-42 RNAi. Embryonic lethality was not fully penetrant for any of the RGA-8 alleles. This is also true for complete loss of toca-2; toca-1 (13%) or wsp-1 (35%).
One explanation for this ability of embryos to sometimes survive without the contribution of increased mrck-1::gfp (Fig. 7) , and decreased nmy-2::gfp (Fig. 6 ), suggesting misregulated CDC-42 results in misregulated MRCK-1 that alters levels of myosin, and also, perhaps its localization. Higher resolution live imaging of myosin during these dynamics events can address this model. Further experiments will need to investigate which of the many cellular processes regulated by CDC-42 are promoted by the RhoGAP-BAR protein RGA-8. All worms were grown at 23°C unless otherwise indicated. Early arrest: includes embryos with cytokinesis defects and other early arrest so that tissue differentiation is defective. Lethal arrest occurs before epidermal morphogenesis begins.
Ventral enclosure: describes embryos with fully differentiated tissues that fail epidermal enclosure so that internal organs end up on the outside (AKA Gex, gut on exterior).
Elongation: describes embryos that enclose but then fail to lengthen along the anterior/posterior axis. Some of these burst after initially enclosing.
MATERIALS AND METHODS
Strains -
All strains used in this study are listed in Table 3 . Strains were either received from the CGC (Caenorhabditis Genetics Center, USA), the NBRP (National Bio-Resource Project, Japan), or individual labs listed below, or were generated for this study. All strains were grown at 23°C unless otherwise stated. flanking arms were generated using primers MSo1402-1403 and the 3' flanking arms were generated using primers MSo1404-1405. Both arms were cloned into the pDD285 vector using Gibson assembly kit from NEB Cat# E2611. To generate deletion mutants, we used co-CRISPR method by the Fire lab to select for worms that have a successful Cas9 cutting event ([55]Arribere et al., 2014). To generate specific point mutants, verified sgRNA and rescue oligos containing the desired point mutation as well as mutated PAM site were coinjected with dpy-10 sgRNA. Silent mutation that inserted a new AvaI restriction enzyme site was engineered on the rescue oligos (MSo1602) to ease the screening process of identifying the mutants. DNA sequencing was done to verify the mutations and inserts for all strains. All strains were back crossed to wild type at least three times to minimize possible off-target effects by the gRNAs and Cas9. Primers used for strain generation are listed in Table 4 . 
RNAi experiments
All RNAi bacterial strains used in this study were administered by the feeding protocol as in 
Live Imaging
For all live imaging shown, embryos at the 2 to 4 cell stage were dissected from adult hermaphrodites and mounted onto 3% agarose pads, covered with #1.5 cover slip, and sealed with Vaseline. Embryos were then incubated at 23˚C for 240 minutes. Imaging was done in a temperature-controlled room set to 23°C on a Laser Spinning Disk Confocal
Microscope with a Yokogawa scan head, on a Zeiss AxioImager Z1m Microscope using the Plan-Apo 63X/1.4NA or Plan-Apo 40X/1.3NA oil lenses. Images were captured on a Photometrics Evolve 512 EMCCD Camera using MetaMorph software, and analyzed using ImageJ. Some images (Fig. 1) were done on a Zeiss Axioskop 2 microscope, using Plan-Apo 40X/1.3NA oil lens, captured with a Roper camera. Controls and mutants were imaged within 3 days of each other with the same imaging conditions. All measurements were performed on raw data. For fluorescent measurements, background intensity was subtracted by using a box or line of the same size and measuring average intensity in the same focal plane, near the embryo. Actin Intensity measurements, protrusion and retraction analysis as previously done ([26]Wallace et al., 2018) on embryos imaged at 2-minute intervals for at least 120 minutes beginning at 240 min after 2 to 4 cell stage.
Myosin measurements
To compare myosin levels as pocket cells meet, a rectangular box enclosing the pocket cells as they first touch (approximately 320min) was drawn (yellow box in Fig. 6C ), Time points shown and measured are those when the epidermal cells first touch based on epidermal Factin signal. To measure myosin puncta on the same focal plane as the epidermis, we co-localized the highest Plin-26::LIFEACT::mCherry intensity with NMY-2::GFP and recorded the highest of three measurements per embryo (Fig. 6B ). Maximum intensity values were recorded after subtracting the average background fluorescence. The graph in Fig. 6B records the relative level of NMY-2::GFP, after normalization of either WT, or WT on control RNAi, to 1.
Statistical Analysis
For grouped data statistical significance was established by performing a two-way Analysis of 
